Current Assets Изменить Дата
Acadia Pharmaceuticals USD 499.17M 6.54M 2023-09
Agios Pharmaceuticals USD 704.35M 52.89M 2023-09
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.99B 461.4M 2023-09
Amgen USD 48.48B 1.1B 2023-09
Biogen USD 8.45B 1.98B 2023-09
BioMarin Pharmaceutical USD 2.96B 5.19M 2023-09
Cytokinetics USD 561.42M 25.16M 2023-09
Dynavax Technologies USD 835.67M 38.21M 2023-09
Enanta Pharmaceuticals USD 422.79M 25.67M 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 15.98B 1.69B 2023-09
Halozyme Therapeutics USD 879.01M 113.26M 2023-09
Incyte USD 4.4B 138.23M 2023-09
Intra Cellular Therapies USD 702.42M 4.35M 2023-09
Ionis Pharmaceuticals USD 2.58B 32.1M 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Regeneron Pharmaceuticals USD 18.63B 1.71B 2023-09
Repligen USD 978.46M 20.13M 2023-09
Rigel Pharmaceuticals USD 95.02M 5.9M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xoma USD 34.5M 3.92M 2023-09



Neurocrine Biosciences Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.